CAU
AVNS

Caxton Associates (UK)’s Avanos Medical AVNS Stock Holding History

Caxton Associates (UK)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
+16,855
New +$395K 0.01% 566
2025
Q2 		– Sell
-27,116
Closed -$389K – 696
2025
Q1 		$389K Buy
+27,116
New +$423K 0.01% 554

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Caxton Associates (UK)'s AVNS Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Avanos Medical (AVNS) in Q2 2026: 16,855 shares worth $419K. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in AVNS as recently as Q1 2025.

Caxton Associates (UK) first reported a position in AVNS in Q1 2025 and has held it in 2 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Caxton Associates (UK) held 16,855 shares of Avanos Medical worth $419K as of Q2 2026.
  • Avanos Medical was a new Caxton Associates (UK) position in Q2 2026.
  • Avanos Medical made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #566 holding.
  • Caxton Associates (UK) first reported a position in Avanos Medical in Q1 2025 and has held it in 2 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.